Increases in rates of 73.0, 48.8, and 36.8 percent seen for children aged 10 to 12 years, 13 to 15 years, and girls
However, these factors are not enough to fully overcome weight-stigmatizing experiences
Risk for self-harm reduced after initiation of melatonin, especially among adolescents with depression/anxiety
Adolescents' positive perceptions of relationships with parents linked to favorable outcomes in young adulthood
However, no significant difference seen in quality-of-life rating for youth with bipolar disorder, those with unipolar depression
Regional clozapine, ECT, and lithium treatment frequency related to lower adolescent excess suicide mortality for 15- to 19-year-olds
Half had history of medication treatment and one-third had psychotherapeutic interventions
Naloxone access and pharmacy naloxone distribution not tied to more adolescent heroin, injection drug use
Increased impact of visceral adipose tissue on blood pressure seen with delayed and irregular sleep midpoint during school and on-break days
Intervention included combination of school-based screening for psychopathology and subsequent referral